This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hankang Biochemical & Pharmaceutical Co., Ltd. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations in Pharmaceutical Composition by Fengnian Han
Introduction
Fengnian Han is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address bacterial infections. His work focuses on enhancing the effectiveness of antibiotics through innovative formulations.
Latest Patents
Fengnian Han holds a patent for a pharmaceutical composition that includes honeysuckle extract and antibiotics. This composition is designed for the prevention and treatment of diseases caused by bacteria. The honeysuckle extract contains iridoid compounds, which, when combined with antibiotics, improve the responsiveness of multi-drug resistant bacteria. This innovation presents a promising clinical application, especially for treating refractory bacterial infections that are resistant to conventional antibiotics.
Career Highlights
Fengnian Han is associated with Hankang Biochemical & Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize the treatment of bacterial infections, particularly in an era where antibiotic resistance is a growing concern.
Collaborations
Fengnian Han collaborates with esteemed colleagues such as Jiangong Shi and Hong Meng. Their combined expertise contributes to the ongoing research and development of effective pharmaceutical solutions.
Conclusion
Fengnian Han's innovative approach to pharmaceutical compositions highlights the importance of combining natural extracts with traditional antibiotics to combat bacterial resistance. His contributions are paving the way for more effective treatments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile